Smooth muscle relaxation

Smooth muscle relaxation is not a specific molecule, protein, or receptor, but rather a physiological process that occurs in smooth muscle tissue. This process involves the reduction of intracellular calcium concentration and increased activity of myosin light chain phosphatase, leading to the dephosphorylation of myosin and cessation of contraction[1][3][7]. Various endogenous substances (such as nitric oxide) and drugs can induce smooth muscle relaxation by acting on different molecular targets—such as receptors (e.g., G protein-coupled receptors), enzymes (e.g., phosphodiesterases), or ion channels—but "smooth muscle relaxation" itself is not a discrete therapeutic target[1][4][5]. Because this entry refers to a process rather than an individual molecular entity, it does not have canonical names, abbreviations, aliases, or direct drug interactions. If you are seeking information about specific targets involved in mediating smooth muscle relaxation (for example, "soluble guanylate cyclase," "phosphodiesterase 5," or "beta-2 adrenergic receptor"), those should be specified individually for structured data extraction.